deepMirror

‍deepmirror is building the foundation model for drug design. AI for drug design is limited by sparse and fragmented data, but deepmirror’s AI-native infrastructure empowers chemistry teams to better harness their data to progress programs faster, with fewer dead ends. With each project, deepmirror’s data sets grow and the model improves, generating even greater outcomes. deepmirror is based in London and is already trusted by 100+ organisations across the globe.

Get in touch

Visit deepMirror's website